申请人:Kyorin Pharmaceutical Co., Ltd.
公开号:US08034819B2
公开(公告)日:2011-10-11
A compound, or a pharmaceutically acceptable salt thereof, represented by the formula (1),
(wherein, the carbon atom marked with an * is in the R-configuration, R1 represents a hydrogen atom, a halogen atom, an amino group, a hydroxyl group, a hydroxyamino group, a nitro group, a cyano group, a sulfamoyl group, a C1-C6 alkyl group, or a C1-C6 alkoxy group, R2 represents a C3-C6 cycloalkylsulfanyl group, a C3-C6 cycloalkylsulfinyl group, or a C3-C6 cycloalkylsulfonyl group, and A represents a substituted or unsubstituted heteroaryl group).
一个化合物,或其药学上可接受的盐,由公式(1)表示,其中,标有*的碳原子处于R构型,R1代表氢原子、卤原子、氨基、羟基、羟基氨基、硝基、氰基、磺酰氨基、C1-C6烷基或C1-C6烷氧基,R2代表C3-C6环烷基磺基、C3-C6环烷基亚砜基或C3-C6环烷基磺酰基,A代表取代或未取代的杂环芳基。